Dynamic Contrast-Enhanced and Diffusion MRI Show Rapid and Dramatic Changes in Tumor Microenvironment in Response to Inhibition of HIF-1α Using PX-478
Open Access
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- Tumor microvascular changes in antiangiogenic treatment: Assessment by magnetic resonance contrast media of different molecular weightsJournal of Magnetic Resonance Imaging, 2004
- In Vivo Assessment of Antiangiogenic Activity of SU6668 in an Experimental Colon Carcinoma ModelClinical Cancer Research, 2004
- Correlation of dynamic contrast enhancement MRI parameters with microvessel density and VEGF for assessment of angiogenesis in breast cancerJournal of Magnetic Resonance Imaging, 2003
- Vascular endothelial growth factor receptor tyrosine kinase inhibitors: PTK787/ZK 222584Seminars in Oncology, 2003
- Vascular endothelial growth factor receptor tyrosine kinase inhibitors: PTK787/ZK 222584Seminars in Oncology, 2003
- Comparison of the return-to-the-origin probability and the apparent diffusion coefficient of water as indicators of necrosis in RIF-1 tumorsMagnetic Resonance in Medicine, 2003
- Hypoxia‐induced pathways in breast cancerMicroscopy Research and Technique, 2002
- Diffusion MRI detects early events in the response of a glioma model to the yeast cytosine deaminase gene therapy strategyGene Therapy, 2000
- A MRI spatial mapping technique for microvascular permeability and tissue blood volume based on macromolecular contrast agent distributionMagnetic Resonance in Medicine, 1997
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996